financetom
Business
financetom
/
Business
/
Market Chatter: Amazon.com Unveils Custom AI Capabilities
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Market Chatter: Amazon.com Unveils Custom AI Capabilities
Apr 24, 2024 10:22 AM

01:11 PM EDT, 04/24/2024 (MT Newswires) -- Amazon.com ( AMZN ) will allow companies to use their own generative artificial intelligence models inside its AI app development platform, The Wall Street Journal reported Wednesday, citing Swami Sivasubramanian, vice president of AI and data at Amazon Web Services.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Price: 176.72, Change: -2.82, Percent Change: -1.57

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Avista Q3 net income rises 57%, reaffirms guidance
Avista Q3 net income rises 57%, reaffirms guidance
Nov 5, 2025
Overview * Avista ( AVA ) Q3 net income rises to $0.36 per share, up from $0.23 last year * Company affirms earnings guidance, Avista Utilities expected at upper end of range * Avista ( AVA ) selects 2025 RFP shortlist, including ownership options Outlook * Avista ( AVA ) confirms 2025 earnings guidance at $2.52 to $2.72 per diluted...
Research Alert: Tech: Q1 Fy 26 Sales Performance Disappoint, Completes The Exosome Divestiture
Research Alert: Tech: Q1 Fy 26 Sales Performance Disappoint, Completes The Exosome Divestiture
Nov 5, 2025
07:45 AM EST, 11/05/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: Bio-Techne ( TECH ) reported Q1 FY 26 (Jun.) adjusted EPS of $0.42 (flat Y/Y), in line with consensus, while revenue declined 1% Y/Y to $286.6M, below consensus. The company...
Ozempic Maker Novo Nordisk Trims Growth Outlook For Obesity Drugs
Ozempic Maker Novo Nordisk Trims Growth Outlook For Obesity Drugs
Nov 5, 2025
Novo Nordisk A/S ( NVO ) on Wednesday reported third-quarter 2025 sales of roughly $11.75 billion (74.98 billion Danish kroner), slightly below the consensus of $11.88 billion. Sales increased by 5% in Danish kroner and 11% at constant currency. GLP-1 diabetes sales increased by 11% to 36.74 billion Danish kroner, and Obesity care sales increased by 18% to 21.11 billion...
Home warranties provider Frontdoor Q3 revenue beats analyst estimates on higher prices, volume
Home warranties provider Frontdoor Q3 revenue beats analyst estimates on higher prices, volume
Nov 5, 2025
Overview * Frontdoor ( FTDR ) Q3 revenue rises 14% to $618 mln, beating analyst expectations * Adjusted EPS for Q3 beats consensus, rising 15% year-over-year * Company repurchased $215 mln of shares YTD, reflecting financial confidence Outlook * Frontdoor ( FTDR ) raises full-year revenue forecast to $2.075 bln-$2.085 bln * Company increases full-year Adjusted EBITDA guidance to $545...
Copyright 2023-2026 - www.financetom.com All Rights Reserved